Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 6.59%253.02M | 0.84%240.75M | -3.75%238.87M | 2.74%961.78M | -1.04%237.5M | 0.86%237.37M | 11.02%238.74M | 0.97%248.18M | 6.66%936.17M | 8.85%240M |
| Cost of revenue | 9.25%196.74M | -0.42%181.93M | -4.74%183.3M | 2.06%736.18M | -3.93%180.99M | 0.13%180.08M | 12.18%182.7M | 1.15%192.41M | 6.06%721.34M | 11.20%188.4M |
| Gross profit | -1.75%56.28M | 4.97%58.82M | -0.35%55.57M | 5.01%225.59M | 9.52%56.51M | 3.22%57.28M | 7.42%56.04M | 0.35%55.77M | 8.72%214.83M | 1.05%51.6M |
| Operating expense | 3.71%32.78M | 6.33%34.04M | -2.92%33.83M | -9.14%128.96M | 4.30%29.6M | -5.63%31.61M | 6.66%32.01M | 6.89%34.85M | 25.15%141.94M | 2.96%28.38M |
| Selling and administrative expenses | 0.27%32.3M | 6.33%34.04M | -2.74%33.49M | 3.55%128.26M | 4.30%29.6M | -2.78%32.21M | 6.66%32.01M | 6.49%34.44M | 10.58%123.86M | 5.35%28.38M |
| -Selling and marketing expense | -1.50%24.63M | 5.00%25.81M | -3.73%25.57M | 6.55%97M | 26.00%20.85M | -1.64%25M | 8.43%24.58M | 0.61%26.56M | 8.44%91.04M | -13.82%16.55M |
| -General and administrative expense | 6.38%7.67M | 10.73%8.23M | 0.61%7.92M | -4.76%31.26M | -26.04%8.75M | -6.54%7.21M | 1.17%7.43M | 32.65%7.87M | 17.00%32.82M | 52.93%11.83M |
| Other operating expenses | --488K | ---- | -18.07%340K | -96.09%707.04K | ---- | ---- | ---- | 55.43%415K | 1,182.67%18.09M | ---- |
| Total other operating income | ---- | ---- | ---- | ---- | ---- | --599K | ---- | ---- | ---- | ---- |
| Operating profit | -8.48%23.5M | 3.16%24.78M | 3.93%21.74M | 32.58%96.63M | 15.89%26.91M | 16.69%25.67M | 8.46%24.02M | -8.93%20.91M | -13.42%72.89M | -1.20%23.22M |
| Net non-operating interest income (expenses) | 21.45%-487K | -211.59%-511K | -366.38%-541K | 1.66%6.4M | -313.93%-505K | -362.69%-620K | -11.56%-164K | 27.50%-116K | 637.84%6.3M | -108.70%-122K |
| Non-operating interest income | ---- | ---- | ---- | 13.79%7.81M | ---- | ---- | ---- | ---- | 324.24%6.86M | ---- |
| Non-operating interest expense | -21.45%487K | 211.59%511K | 366.38%541K | 149.35%1.4M | 313.93%505K | 362.69%620K | 11.56%164K | -27.50%116K | -26.22%563.35K | -43.13%122K |
| Net investment income | -84.09%247.03K | 2.82%1.55M | ||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | 1.09%-3.63M | -364.26%-2.64M | -199.24%-1.57M | -102.91%-9.78M | -138.11%-6.59M | -200.82%-3.67M | -99.68%999K | -111.34%-523K | 1,037.62%336.4M | 19.29%17.29M |
| Special income (charges) | -28.14%209.7K | -57.98%291.82K | ||||||||
| Less:Other special charges | ---- | ---- | ---- | 28.14%-209.7K | ---- | ---- | ---- | ---- | 57.98%-291.82K | ---- |
| Other non-operating income (expenses) | -1.24%2.31M | -29.87%2.96M | -49.05%3.07M | 27.25%7.49M | 119.45%2.29M | -53.04%2.34M | 154.03%4.22M | 167.13%6.02M | 68.42%5.89M | -761.76%-11.75M |
| Income before tax | -8.57%21.69M | -15.44%24.59M | -13.68%22.7M | -76.09%101.2M | -22.81%22.1M | -22.16%23.72M | -91.31%29.08M | -11.38%26.3M | 251.72%423.31M | -28.93%28.64M |
| Income tax | 10.87%6.09M | 6.18%5.77M | 0.53%5.11M | -2.62%24.66M | 0.78%8.64M | -13.03%5.49M | 7.88%5.44M | -5.64%5.09M | 30.63%25.32M | 57.17%8.58M |
| Net income | -14.43%15.6M | -20.41%18.82M | -17.09%17.58M | -80.77%76.54M | -32.90%13.46M | -24.55%18.23M | -92.82%23.64M | -12.66%21.21M | 294.16%397.99M | -42.41%20.06M |
| Net income continuous operations | -14.43%15.6M | -20.41%18.82M | -17.09%17.58M | -80.77%76.54M | -32.90%13.46M | -24.55%18.23M | -92.82%23.64M | -12.66%21.21M | 294.16%397.99M | -42.41%20.06M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | -14.43%15.6M | -20.41%18.82M | -17.09%17.58M | -80.77%76.54M | -32.90%13.46M | -24.55%18.23M | -92.82%23.64M | -12.66%21.21M | 294.15%397.99M | -42.41%20.06M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -14.43%15.6M | -20.41%18.82M | -17.09%17.58M | -80.77%76.54M | -32.90%13.46M | -24.55%18.23M | -92.82%23.64M | -12.66%21.21M | 294.15%397.99M | -42.41%20.06M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -14.51%0.0218 | -20.54%0.0263 | -17.17%0.0246 | -80.79%0.107 | -33.10%0.0188 | -24.56%0.0255 | -92.82%0.0331 | -12.90%0.0297 | 292.60%0.5571 | -42.54%0.0281 |
| Diluted earnings per share | -14.51%0.0218 | -20.30%0.0263 | -16.89%0.0246 | -80.78%0.107 | -33.10%0.0188 | -24.56%0.0255 | -92.84%0.033 | -12.94%0.0296 | 293.50%0.5568 | -42.42%0.0281 |
| Dividend per share | 0.00%0.03 | 20.00%0.03 | 0 | 75.86%0.085 | 0.03 | 20.00%0.03 | 7.14%0.025 | 0 | 20.83%0.0483 | 0 |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.